Become a Franchise Trade Now BA Connect Open an Account Reactivation KYC Modification DP Login
Hot Pursuit
Prev Next
As on Apr 25, 2024 12:00 AM Your results on : Hot Pursuit    
Syngene Intl records PAT of Rs 189 crore in Q4; EBITDA margin at 36%
25-Apr-2024 (12:22)

Material costs declined by 30.9% YoY to Rs 202.8 crore in the fourth quarter due to reversal of inventory provisions of Rs 20.3 crore that were created in prior quarters of FY24. This relates to reassessment of inventory provisioning classified as a change in accounting estimate.

For Q4 FY24, staff costs added up to Rs 250.2 crore (down 1% YoY), other direct costs aggregated to Rs 24.6 crore (down 10.1% YoY) and other expenses amounted to Rs 112.4 crore (up 10% YoY).

EBITDA fell by 1.2% to Rs 333 crore in Q4 FY24 from Rs 336.9 crore in Q4 FY23. EBITDA margin was 36% in Q4 FY24 as against 33% in Q4 FY23.

Profit before tax in Q4 FY24 stood at Rs 209 crore, down by 9.5% from Rs 230.9 crore in Q4 FY23.

For FY24, Syngene recorded net profit and revenues of Rs 510 crore (up 9.8% YoY) and 3,488.6 crore (up 9.3% YoY), respectively.

Jonathan Hunt, managing director and chief executive officer, Syngene International, said, ?While the fourth quarter performance came in lower than expected, the underlying driver - reduced demand for research and development services within US biotech stemming from a difficult funding environment - is well understood and already showing positive signs of recovery.

Despite the business environment, we delivered growth during the year. This resilience is the result of our broad operating span and the investments made to establish our development and manufacturing divisions with biologics, in particular, delivering a strong performance throughout the year.

I?m encouraged by the recent step up in new funding into US biotech and expect this to drive a recovery in demand for research and development services translating into revenue growth in the latter part of the year.

Looking ahead, we expect revenue growth in fiscal year 2025 to be in the range of high single digits to low double digits with momentum building up during the year. We expect the EBITDA margin to be similar to the level delivered in fiscal year 2024 and PAT growth in single digits.?

Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.

The scrip shed 0.33% to currently trade at Rs 691.90 on the BSE.

Raj Oil Mills Ltd leads gainers in 'B' group
25-Apr-2024 (12:15)
Indian Hotels Q4 PAT climbs 27% YoY to Rs 418 cr
25-Apr-2024 (12:00)
Hitachi Energy India Ltd leads gainers in 'A' group
25-Apr-2024 (12:00)
Oracle Financial Services Q4 PAT rises 16% YoY; declares dividend of Rs 240/ share
25-Apr-2024 (11:19)
Volumes jump at Kotak Mahindra Bank Ltd counter
25-Apr-2024 (11:00)
Jubilant Pharmova announces conclusion of Montreal facility audit by US FDA
25-Apr-2024 (10:43)
LTIMindtree slides after Q4 PAT drops 6% QoQ to Rs 1,100 cr
25-Apr-2024 (10:29)
Supreme Petrochem Q4 PAT slides 17% YoY to Rs 132 cr
25-Apr-2024 (10:25)
MAS Financial Services spurts after Q4 PAT climbs 22% YoY to Rs 68 cr
25-Apr-2024 (10:18)
HUL slips as Q4 PAT slides 6% YoY; declares dividend of Rs 24/share
25-Apr-2024 (10:06)
Utilties shares gain
25-Apr-2024 (10:00)
Capital Goods shares gain
25-Apr-2024 (10:00)
Industrials shares gain
25-Apr-2024 (10:00)
Axis Bank rallies on turnaround PAT of Rs 7,130 cr in Q4
25-Apr-2024 (09:54)
Kotak Bank tumbles after RBI places curbs on digital onboarding & credit card issuance
25-Apr-2024 (09:26)
Kotak Mahindra Bank Ltd Slips 9.4%
25-Apr-2024 (09:30)
Macrotech Developers Ltd Spurts 2.89%
25-Apr-2024 (09:30)
Rites inks MoU with Damodar Valley Crop
25-Apr-2024 (08:28)
Axis Bank records turnaround PAT of Rs 7,130 cr in Q4
24-Apr-2024 (17:25)
Connect with us :   
Globe
About us
Our Services
Milestones
Memberships
Core Values
Investor Relations
Product & Services
Broking
Institutional Broking
PMS
Clearing Services
Distribution
Research
Depository
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Mobile App Demo
ODIN User Manual
Client Reactivation
Segment activation
KYC Modification
Annual Income Updation
MTF Activation
Nomination
Back Office
Back Office
CMS
CMS-TM
KYC/KDC Status
Mutual Fund
CAMS
RMS Policy
Helpdesk
Download Forms
Useful Links
BSE
NSE
SEBI
RBI
MCX
NCDEX
Exchange Holidays
Exchange guidelines on margin collection
Attention Investors
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures
Scores

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances please write to
Investor_trading@globecapital.com /  igr@globecapital.com (For Trading)     globedp@globecapital.com (For DP)    Investor_pms@globecapital.com (For PMS)     
commigr@globecapital.com (For Commodities)
Equity SEBI Registration No INZ000177137, Exchange Registration Nos : NSE TM Code - 06637, Clearing No.- M50302|BSE Clearing No: 3179|MSEI TM Code - 1004 ,Clearing No.- 4| MCX TM No: 8091,Clearing No: 8090 | NCDEX TM No:1287, Clearing No: -M51085|ICEX TM ID-2084 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No :INH100001187 | SEBI PMS Registration No:INP000002361 CMBPID NCL CM :- IN555502
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions